Variant report
Variant | nsv593081 |
---|---|
Chromosome Location | chr3:196058795-196062518 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:196057685..196059203-chr3:196062080..196064140,2 | MCF-7 | breast: | |
2 | chr3:196014212..196016306-chr3:196062015..196064940,3 | MCF-7 | breast: | |
3 | chr3:196057685..196059203-chr3:196062080..196064140,2 | MCF-7 | breast: | |
4 | chr3:196043597..196046330-chr3:196059490..196061514,2 | K562 | blood: | |
5 | chr3:196043015..196046706-chr3:196061951..196066451,7 | K562 | blood: | |
6 | chr3:196062380..196065036-chr3:196160453..196162910,2 | MCF-7 | breast: | |
7 | chr3:196044943..196046563-chr3:196056014..196058811,2 | MCF-7 | breast: | |
8 | chr3:196013231..196016156-chr3:196060060..196062117,2 | MCF-7 | breast: | |
9 | chr3:196043597..196046565-chr3:196058227..196060990,3 | K562 | blood: | |
10 | chr3:196043015..196047197-chr3:196061951..196068288,11 | K562 | blood: | |
11 | chr3:196012576..196016636-chr3:196061383..196069148,11 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213123 | chromatin interactions |
ENSG00000235897 | chromatin interactions |
ENSG00000161217 | chromatin interactions |
ENSG00000272741 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12497601 | chr3:196058795-196058796 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs555622100 | chr3:196058817-196058818 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs551605786 | chr3:196058835-196058836 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs386670162 | chr3:196058863-196058864 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs73212183 | chr3:196058864-196058865 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs73212184 | chr3:196058920-196058921 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs562636577 | chr3:196058927-196058928 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs566535672 | chr3:196058939-196058940 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs12496368 | chr3:196058968-196058969 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs528624968 | chr3:196058969-196058970 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs546673487 | chr3:196059035-196059036 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs370883634 | chr3:196059084-196059085 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs533041146 | chr3:196059091-196059092 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs551278877 | chr3:196059103-196059104 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs569486820 | chr3:196059120-196059121 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs536857259 | chr3:196059125-196059126 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs55673262 | chr3:196059139-196059140 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs369834525 | chr3:196059159-196059160 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs376375633 | chr3:196059299-196059300 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs534764195 | chr3:196059313-196059314 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs140965251 | chr3:196059327-196059328 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs200124575 | chr3:196059365-196059366 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs201519946 | chr3:196059370-196059371 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs564720419 | chr3:196059377-196059378 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs527675901 | chr3:196059379-196059380 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs557687569 | chr3:196059381-196059382 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs575864429 | chr3:196059439-196059440 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs189212043 | chr3:196059455-196059456 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs66744350 | chr3:196059466-196059467 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs374282556 | chr3:196059483-196059484 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs145852836 | chr3:196059484-196059485 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs576695362 | chr3:196059502-196059503 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs531851018 | chr3:196059565-196059566 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs577067906 | chr3:196059576-196059577 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs150352789 | chr3:196059590-196059591 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs550071888 | chr3:196059615-196059616 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs571461516 | chr3:196059631-196059632 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs193067716 | chr3:196059698-196059699 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs544134464 | chr3:196059719-196059720 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs184600443 | chr3:196059747-196059748 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs532645479 | chr3:196059749-196059750 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs570744569 | chr3:196059791-196059792 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs532392912 | chr3:196059821-196059822 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs551215614 | chr3:196059846-196059847 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs57703189 | chr3:196059856-196059857 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs563251900 | chr3:196059859-196059860 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs73212186 | chr3:196059861-196059862 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs188249884 | chr3:196059877-196059878 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs180729178 | chr3:196059919-196059920 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs528161021 | chr3:196059955-196059956 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 19653912 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cervical cancer | 21062161 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 16397240 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20299530 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 16760732 | CNVD |
Schizophrenia | 22118685 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 20970697 | CNVD |
Developmental delay | 18471269 | CNVD |
Intellectual disability | 22045946 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Uveal melanoma | 20484589 | CNVD |
3q29 microdeletion syndrome | 20500065 | CNVD |
Biliary cancer | 20453639 | CNVD |
3q29 microdeletion syndrome | 22283845 | CNVD |
3q29 microdeletion syndrome | 21626679 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:196047600-196063600 | Weak transcription | NHEK | skin |
2 | chr3:196051400-196063600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
3 | chr3:196052000-196062600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr3:196054600-196061800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr3:196054600-196091000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
6 | chr3:196054800-196060800 | Weak transcription | K562 | blood |
7 | chr3:196054800-196064400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr3:196057800-196062600 | Weak transcription | Hela-S3 | cervix |
9 | chr3:196059800-196060000 | Enhancers | Esophagus | oesophagus |
10 | chr3:196060200-196062600 | Weak transcription | Esophagus | oesophagus |
11 | chr3:196060800-196061000 | Enhancers | K562 | blood |
12 | chr3:196061000-196061200 | Genic enhancers | K562 | blood |
13 | chr3:196061200-196062400 | Weak transcription | K562 | blood |
14 | chr3:196061800-196063000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr3:196062400-196062800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr3:196062400-196063000 | Active TSS | HepG2 | liver |
17 | chr3:196062400-196063200 | Enhancers | K562 | blood |
18 | chr3:196062400-196063400 | Enhancers | HMEC | breast |